Business

NetScientific appoints Prof. Stephen Smith as NED

NetScientific appoints Prof. Stephen Smith as NED.

articleEmv Capital PlcFebruary 17, 20163/company/emv-capital-plc/news/netscientific-appoints-prof-stephen-smith-as-ned
NetScientific appoints Prof. Stephen Smith as NED

About this update from Emv Capital Plc

[{"type":"text","content":"\n \nRNS Number : 2646P NetScientific PLC 17 February 2016  \n\nNetScientific plc\n \nNetScientific appoints Professor Stephen Smith as Non-Executive Director\n \nLondon, UK - 17 February 2016 - NetScientific plc (\"NetScientific\" or the \"Group\", AIM: NSCI), the transatlantic biomedical and healthcare technology group, appoints Professor Stephen Smith as Non-Executive Director, with effect from today. Professor Smith will also join both the audit and remuneration committees.\nStephen has held senior leadership roles in the NHS and academia. He has had a long and distinguished career as a clinician scientist, Head of Department, Dean and CEO with the Medical Research Council, University of Cambridge, Imperial College, London and Imperial College Healthcare NHS Trust.\nHe was responsible for the largest merger in the NHS, the creation of the UK's first Academic Health Science Centre in 2007. The merger brought together four London based NHS Trusts and ultimately led to the creation of Imperial College Healthcare NHS Trust, where Stephen served for four years as the first CEO. He also retained his position as Dean of the Faculty of Medicine at Imperial College, London and was responsible for facilitating the commercialisation of life sciences and healthcare. \nDuring his career, Stephen has spun two companies out of Cambridge - Metris Therapeutics Ltd and GNI Group Ltd. GNI was established as a start up in Japan in 2001 and successfully achieved an Initial Public Offering (IPO) on the Tokyo Stock Exchange six years later.  \nStephen has extensive non-executive experience serving on the Boards of the National Healthcare Group Singapore which developed integrated care through nine polyclinics. In Australia, he was on the Board of the Royal Melbourne Hospital and the Victorian Comprehensive Cancer Centre, a $1billion project to create a fully integrated cancer care facility that brings together an integrated research, service and education offering to four million patients in Victoria. \nCommenting on the appointment, Sir Richard Sykes, Chairman of NetScientific said: \"Stephen's impressive leadership experience in mergers and commercialisation internationally further strengthens the Group. We look forward to welcoming Stephen to the team as we continue to build our subsidiary companies towards develop...

More updates from Emv Capital Plc